Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated on: 30 May, 2024|Author: Getaka | Social: X Twitter Profile

Fundamental Analysis of Camlin Fine Sciences Ltd

About the Company - Camlin Fine Sciences Ltd

Camlin Fine Sciences Ltd. is a Public Limited Listed company incorporated on 30/11/1993 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L74100MH1993PLC075361 and registration number is 075361. Currently company belongs to the Industry of Chemicals - Others. Company’s Total Operating Revenue is Rs. 685.51 Cr. and Equity Capital is Rs. 15.70 Cr. for the Year ended 31/03/2022.
INDUSTRYADDRESSCONTACT
Chemicals - Speciality - OthersFloor 2 to 5, In GS Point, CST Road, Kalina, Mumbai Maharashtra 400098secretarial@camlinfs.com
https://www.camlinfs.com
Management
NamePosition Held
Mr. Ashish DandekarChairman & Managing Director
Mr. Nirmal MomayaManaging Director
Mr. Arjun DukaneExecutive Director
Mr. Mahabaleshwar PalekarIndependent Director
Mr. Pradip KanakiaIndependent Director
Mr. Amol ShahIndependent Director
Mr. Sutapa BanerjeeIndependent Director
Mr. Joseph Conrad D'souzaIndependent Director
Ms. Anagha DandekarNon Exe.Non Ind.Director
Mr. Harsha RaghavanNon Exe.Non Ind.Director

Basic Stock Data of Camlin Fine Sciences Ltd

Last Updated: May 13, 2024, 12:20 pm

Market Cap 1,645 Cr.
Current Price 98.6
High / Low186/88.4
Stock P/E
Book Value 56.3
Dividend Yield0.00 %
ROCE10.2 %
ROE5.70 %
Face Value 1.00
PEG Ratio0.00

Camlin Fine Sciences Ltd Quarterly Results

MonthDec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
Sales298327331311381389384483388427420406386
Expenses251276285289326365337428338383381381363
Operating Profit47504623552447555044392523
OPM %16%15%14%7%14%6%12%11%13%10%9%6%6%
Other Income121116211310-8622
Interest71210971019181210102014
Depreciation13121313131614141618191921
Profit before tax28293314120152632816-12-10
Tax %30%45%27%612%33%33%75%61%28%59%25%-72%-47%
Net Profit191624-4271341023312-21-14
EPS in Rs1.211.121.75-0.432.250.960.380.831.530.580.93-1.16-0.70

Last Updated: May 11, 2024, 11:49 am

Camlin Fine Sciences Ltd Quarterly Chart

Camlin Fine Sciences Ltd Profit & Loss

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023TTM
Sales3353745095584895347218921,0491,1871,4121,6821,640
Expenses3063274464743975027058199141,0001,2541,4711,483
Operating Profit2947638492321673135187158211157
OPM %9%13%12%15%19%6%2%8%13%16%11%13%10%
Other Income121099-11412143533-410
Interest17202524243132414842416451
Depreciation14141216172227293344566372
Profit before tax1124355350-6-311758105948044
Tax %64%36%18%-4%28%26%22%82%49%38%36%50%
Net Profit415295536-4-2433065604018
EPS in Rs0.401.613.045.743.71-1.08-2.440.052.504.003.873.321.88
Dividend Payout %62%19%12%8%12%0%0%0%0%0%0%0%

Camlin Fine Sciences Ltd Profit & Loss Yearly Chart

Camlin Fine Sciences Ltd Growth

Compounded Sales Growth
10 Years:12%
5 Years:13%
3 Years:11%
TTM:-4%
Compounded Profit Growth
10 Years:%
5 Years:%
3 Years:%
TTM:-234%
Stock Price CAGR
10 Years:12%
5 Years:10%
3 Years:-18%
1 Year:-42%
Return on Equity
10 Years:4%
5 Years:4%
3 Years:2%
Last Year:-7%

Last Updated: May 13, 2024, 12:20 pm

Camlin Fine Sciences Ltd Balance Sheet

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Sep 2023
Equity Capital99910101012121213161617
Reserves445684125167202359338391585732804926
Borrowings125126150160180331373461539550646801693
Other Liabilities108178126131123126273276290328396425378
Total Liabilities2863693694264796691,0161,0871,2321,4751,7902,0452,014
Fixed Assets748383106140201278272306584601858846
CWIP212232581459179242154350
Investments11111191151177788
Other Assets2082842623163134426097457408619661,1361,110
Total Assets2863693694264796691,0161,0871,2321,4751,7902,0452,014

Camlin Fine Sciences Ltd Reserves and Borrowings Chart

Camlin Fine Sciences Ltd Cash Flow

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
Cash from Operating Activity -3256274672-9-15-98611714551
Cash from Investing Activity -9-19-32-26-66-70-149-2-90-133-249-125
Cash from Financing Activity 38-21-6-15-7911822633913660
Net Cash Flow-316-124-1131815-12332-14

Camlin Fine Sciences Ltd Financial Efficiency Indicators Chart

Camlin Fine Sciences Ltd Share Holding Pattern

MonthMar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
Promoters21.62%21.61%21.61%21.60%17.56%17.56%17.55%17.55%17.55%16.52%48.03%48.03%
FIIs4.71%5.28%5.01%4.81%10.50%10.74%11.32%10.94%10.18%10.11%1.61%0.99%
DIIs20.21%19.71%19.03%17.88%14.48%14.19%13.53%12.53%12.32%9.31%3.89%3.75%
Government0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.03%0.03%0.00%0.00%
Public53.46%53.40%54.35%55.70%57.46%57.51%57.60%58.97%59.89%64.01%46.46%47.22%
No. of Shareholders38,71241,54351,03856,39455,27757,83557,90454,19752,92152,27857,09862,098

Camlin Fine Sciences Ltd Shareholding Pattern Chart

No. of Camlin Fine Sciences Ltd Shareholders

Camlin Fine Sciences Ltd Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)
ICICI Prudential Smallcap Fund42831361.1670.22
HSBC Small Cap Equity Fund - OLD4000002.096.28
ICICI Prudential Dividend Yield Equity Fund2240820.153.67
Motilal Oswal Nifty Microcap 250 Index Fund820170.351.34

Camlin Fine Sciences Ltd ROCE Trend

Camlin Fine Sciences Ltd EPS Trend

Camlin Fine Sciences Ltd Key Financial Ratios

MonthMar 23Mar 22Mar 21Mar 20Mar 19
FaceValue1.001.001.001.001.00
Basic EPS (Rs.)3.454.654.132.500.05
Diluted EPS (Rs.)3.414.563.682.500.05
Cash EPS (Rs.)6.517.428.605.172.64
Book Value[Excl.RevalReserv]/Share (Rs.)48.1843.2647.8137.6735.21
Book Value[Incl.RevalReserv]/Share (Rs.)52.2548.5255.6737.6735.21
Revenue From Operations / Share (Rs.)107.0489.9593.1186.5273.58
PBDIT / Share (Rs.)13.4411.8414.6611.066.80
PBIT / Share (Rs.)9.468.2711.198.364.41
PBT / Share (Rs.)5.125.998.244.801.38
Net Profit / Share (Rs.)2.533.855.132.460.25
NP After MI And SOA / Share (Rs.)3.323.874.002.500.04
PBDIT Margin (%)12.5513.1615.7412.789.24
PBIT Margin (%)8.839.1912.019.655.99
PBT Margin (%)4.776.668.855.541.87
Net Profit Margin (%)2.364.285.502.840.34
NP After MI And SOA Margin (%)3.094.294.292.880.06
Return on Networth / Equity (%)6.929.169.437.580.15
Return on Capital Employeed (%)11.7210.7714.2014.768.53
Return On Assets (%)2.523.373.432.450.05
Long Term Debt / Equity (X)0.540.580.500.520.52
Total Debt / Equity (X)1.040.940.991.221.19
Asset Turnover Ratio (%)0.460.480.520.580.60
Current Ratio (X)1.371.501.661.231.46
Quick Ratio (X)0.650.870.990.680.84
Inventory Turnover Ratio (X)1.291.651.791.972.27
Dividend Payout Ratio (NP) (%)0.000.000.000.001080.61
Dividend Payout Ratio (CP) (%)0.000.000.000.0021.09
Earning Retention Ratio (%)0.000.000.000.00-980.61
Cash Earning Retention Ratio (%)0.000.000.000.0078.91
Interest Coverage Ratio (X)3.615.204.983.112.25
Interest Coverage Ratio (Post Tax) (X)1.852.692.741.691.08
Enterprise Value (Cr.)2685.652687.502251.73959.50998.38
EV / Net Operating Revenue (X)1.601.901.900.911.12
EV / EBITDA (X)12.7214.4612.057.1512.11
MarketCap / Net Operating Revenue (X)1.191.551.500.450.67
Retention Ratios (%)0.000.000.000.00-980.61
Price / BV (X)2.663.313.301.191.64
Price / Net Operating Revenue (X)1.191.551.500.450.67
EarningsYield0.020.020.020.060.00

Camlin Fine Sciences Ltd Profitability Ratios (%)

Camlin Fine Sciences Ltd Liquidity Ratios

Camlin Fine Sciences Ltd Liquidity Ratios (%)

Camlin Fine Sciences Ltd Interest Coverage Ratios (%)

Camlin Fine Sciences Ltd Valuation Ratios

Fair Value

Fair Value: ₹49.10

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

Overvalued: 50.20% compared to the current price ₹98.6

Default values used*: Deafault value of 15 for Stock P/E is used

Intrinsic Value: ₹46.38

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
  • EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators along with EPS growth.

Overvalued: 52.96% compared to the current price ₹98.6

Default values used*: Deafault value of 15 for Stock P/E is used

Last 5 Year EPS CAGR: -5.54%

*Investments are subject to market risks

Strength and Weakness of Camlin Fine Sciences Ltd Stock

Unable to fetch valid data for stock valuation.

FAQ

What is the latest fair value of Camlin Fine Sciences Ltd?

The latest fair value of Camlin Fine Sciences Ltd is ₹49.10.

What is the Market Cap of Camlin Fine Sciences Ltd?

The Market Cap of Camlin Fine Sciences Ltd is 1,645 Cr..

What is the current Stock Price of Camlin Fine Sciences Ltd as on 18 May 2024?

The current stock price of Camlin Fine Sciences Ltd as on 18 May 2024 is 98.6.

What is the High / Low of Camlin Fine Sciences Ltd stocks in FY 2024?

In FY 2024, the High / Low of Camlin Fine Sciences Ltd stocks is ₹186/88.4.

What is the Stock P/E of Camlin Fine Sciences Ltd?

The Stock P/E of Camlin Fine Sciences Ltd is .

What is the Book Value of Camlin Fine Sciences Ltd?

The Book Value of Camlin Fine Sciences Ltd is 56.3.

What is the Dividend Yield of Camlin Fine Sciences Ltd?

The Dividend Yield of Camlin Fine Sciences Ltd is 0.00 %.

What is the ROCE of Camlin Fine Sciences Ltd?

The ROCE of Camlin Fine Sciences Ltd is 10.2 %.

What is the ROE of Camlin Fine Sciences Ltd?

The ROE of Camlin Fine Sciences Ltd is 5.70 %.

What is the Face Value of Camlin Fine Sciences Ltd?

The Face Value of Camlin Fine Sciences Ltd is 1.00.

About the Author

Author Avatar
Getaka

Getaka, CFA, a financial analyst with 15 years of experience in the industry. Getaka holds an MBA degree and the Chartered Financial Analyst designation, demonstrating his profound understanding of financial analysis and investment management. Throughout his career, he has conducted numerous financial analyses and due diligence processes for companies in the industry, and has a strong track record of identifying key trends and opportunities. He leverages his expertise to deliver a thorough financial analysis of a company, encompassing its financial performance, key ratios, future prospects, and risks. Getaka is committed to providing accurate, reliable, and trustworthy information to help readers make informed decisions about their finances and investments.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Camlin Fine Sciences Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE